ChromaGenix will combine industry expertise, academic innovation, and $35 million in planned investment to develop and scale next-generation purification technologies for gene therapies, vaccines, and immunotherapies. LigaTrap Technologies (now ChromaGenix) is an innovative North Carolina biotechnology company offering proprietary purification technologies for production of antibody-based medications, viral vaccines, and gene therapies. We’re pleased to announce […]
CARLSBAD, CA – Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its strategic growth and commitment to advancing cutting-edge solutions for laboratories worldwide. This transformation solidifies Pictor Holdings Inc. as the parent company, which will continue to proudly operate […]
Munich-based lab automation startup raised €2.77M in a pre-seed funding round led by NAP (formerly Cavalry Ventures) with PUSH, Acurio Ventures, OMA Business Angels, and LANA Ventures also participating. Fundraising Announcement Munich – UniteLabs, a startup specializing in lab automation for biotechnology, has raised €2.77 million in a pre-seed funding round led by NAP (formerly Cavalry Ventures). […]
VANCOUVER, British Columbia — Semaphore Solutions, a leader in laboratory informatics solutions, announces a new investment from Cypress Ridge Capital (“CRC”) to further accelerate the growth of its flagship platform, Labbit. The growth equity investment builds on Cypress Ridge’s initial investment in February 2023 and supports the continued organic and inorganic expansion of Labbit as […]
FARMINGDALE, N.Y. — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, […]
Building the world’s largest biobank with data from global populations to accelerate biomarker and drug discovery and development of next-generation diagnostics. Secured $25M in funding from F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics. MIAMI — Galatea Bio, a leader in AI-driven genomic research […]
mo:re introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models. The user-friendly platform enables verifiable, standardized results without requiring expertise in specific organ systems. The Hamburg-based life science start-up mo:re announced the launch of their first product at the SLAS 2025 in San Diego, the world’s leading […]
2024 was characterized by continuity for INTEGRA Biosciences. With sales of CHF 156 million, the company remained at the previous year’s level despite a difficult first quarter. Compared to the period before the COVID-19 pandemic, the company has doubled in size, underlining its sustainable growth. Agility and growth in a challenging market environment The market […]
Investment from Audax Strategic Capital aims to help extend growth runway and accelerate M&A. NEW YORK & PITTSBURGH — Audax Strategic Capital (“ASC” or “Audax”), a provider of customized, mid-hold equity solutions, announced today an investment in TCP Analytical, a portfolio company of Riverarch Equity Partners (“Riverarch”) and an established manufacturer and distributor of specialty […]
SAN DIEGO — Telesis Bio, a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced that it has entered into a convertible preferred stock purchase agreement (the Purchase Agreement) to sell shares of a new series of convertible preferred stock in a private […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
